Details of the Drug

General Information of Drug (ID: DMBX9HV)

• Drug Name: Inodiftagene vixteplasmid
• Synonyms: BC-819

Indication

Disease Entry	ICD 11	Status	REF
Bladder cancer	2C94	Phase 2	[1]

• Drug Type: Gene therapy
• Cross-matching ID:
  UNII: 98YK326XZ6
  DrugBank ID: DB16017
  TTD ID: DE2V3Y

References

• [1] ClinicalTrials.gov (NCT03719300) Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC. U.S. National Institutes of Health.